KCG
MDCO

Knight Capital Group’s Medicines Co MDCO Stock Holding History

Knight Capital Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$225K Buy
+7,307
New +$244K ﹤0.01% 2585

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Knight Capital Group's MDCO Position: Q2 2013 in Review

Knight Capital Group opened a new position in Medicines Co (MDCO) in Q2 2013: 7,307 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #2585 among its holdings.

168 funds tracked by Wall St. Rank hold MDCO as of Q2 2013.

  • Knight Capital Group held 7,307 shares of Medicines Co worth $225K as of Q2 2013.
  • Medicines Co was a new Knight Capital Group position in Q2 2013.
  • Medicines Co made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2585 holding.
  • 168 funds tracked by Wall St. Rank held Medicines Co as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.